This systematic review underscores the transformative potential of cyclodextrins (CDs) and polymers in enhancing cannabinoid delivery systems. Analyzing 55 eligible studies from an initial pool of 221 articles, we revealed significant advancements in the solubility, stability, and bioavailability of cannabinoids through complexation with CDs. Chemically modified CDs, such as RM-β-CD and HP-β-CD, exhibited superior performance, optimizing the pharmacokinetics of cannabinoids like Δ9-THC and CBD by improving drug stability, solubility, and therapeutic efficacy. The review highlighted promising applications in anticancer, antimicrobial, and CNS-targeted therapies, demonstrating increased cytotoxicity against cancer cells and enhanced wound healing capabilities. CDs also showed potential in ocular and topical applications, enhancing solubility and permeability for conditions like glaucoma. Despite the predominance of CDs due to their well-established benefits and cost-effectiveness, the review identified a need for further exploration of other macrocycles, such as cucurbiturils and calixarenes, in cannabinoid delivery. Overall, this review emphasizes the pivotal role of CDs and polymers in addressing solubility challenges associated with poorly water-soluble drugs, advocating for continued research to expand their clinical applications and improve therapeutic outcomes across various medical contexts.